Know What's Happening in Earnings Calls
Know What's Happening in Earnings Calls
Micron posts $23.9B revenue, sparks analyst split on AI memory outlook
Micron Technology reported fiscal Q2 revenue of $23.86 billion, nearly tripling year‑over‑year, and posted non‑GAAP earnings of $12.20 per share. Citi responded by cutting its price target to $425 from $510, highlighting a debate among analysts about the durability of the AI‑driven memory boom.
HNI Corp reported third‑quarter 2025 non‑GAAP EPS of $1.10, a 7% year‑over‑year increase, and posted a record non‑GAAP operating margin of 10.8%. Workplace furnishings sales rose 3% organically, with segment margin surpassing 12% after a 40‑basis‑point improvement. Management reaffirmed its full‑year outlook, projecting a fourth consecutive year of double‑digit EPS growth and highlighting high‑single‑digit revenue growth in Q4, driven by pricing actions and an extra fiscal week. The pending Steelcase acquisition is expected to generate $120 million in synergies and $1.20 of EPS accretion, while targeting net leverage of 2.1× post‑close and a return to 1‑1.5× within two years.
Nvidia announced a return to the consumer PC market with new low‑power system‑on‑chip devices slated for Dell, Lenovo and other OEMs. The chips combine CPU and GPU functions, aiming to extend battery life and diversify Nvidia’s revenue beyond data centers....
Soleno Therapeutics reported $190.4 million in net revenue for fiscal 2025, representing less than nine months of commercial sales of its VICAT XR therapy. The company turned profitable, posting $20.9 million net income and generating $48.7 million of operating cash in Q4, ending the...
Montrose Environmental Group reported first‑quarter 2022 revenue of $134.7 million, a modest 0.6% year‑over‑year increase, driven by strong organic growth in its measurement‑and‑analysis and remediation segments. PFAS water‑treatment and biogas services surged, while COVID‑related CTEH revenues continued to normalize below historic...
Astec Industries reported a strong Q4 2025, with adjusted EBITDA climbing 55.7% year‑over‑year to $27.1 million and net sales up 20.1% thanks to robust demand for asphalt and concrete plants and the TerraSource acquisition. The company’s backlog expanded to $449.5 million, including...
Teladoc Health reported Q2 2025 revenue of $631.9 million, a modest 1.6% decline YoY, while adjusted EBITDA reached $69.3 million, hitting the high end of guidance. Integrated care drove growth, delivering $391.5 million in revenue and expanding U.S. membership to 102.4 million, surpassing 100 million members....
Mirum Pharmaceuticals reported $521 million in 2025 net product sales, a 55% year‑over‑year increase driven by Livmarli and bile‑acid medicines, surpassing guidance. Operating expenses rose to $543 million, yet the company generated positive cash flow and ended the year with $391 million in...
Ibotta reported Q4 2025 revenue of $83.3 million, a 16% year‑over‑year decline, and non‑GAAP gross margin of 80%, down roughly 800 basis points. The company highlighted strong traction for its LiveLift pilots, with an 83% re‑up rate, and announced a...
The earnings picture has continuedto provide support for this now 40-month old bull market. With Q4 earnings season soon wrapping up (with 425 companies having reported), 75% have beaten estimates by an average of 773 bps. The dollar estimate has...
MELI posting a very strong Q4 2025: • Revenue $8.8B vs Est. $8.5B • TPV: $83.7B (+42% YoY) • GMV: $19.9B (+37% YoY) • Credit portfolio $12.5B
Snowflake (SNOW) shares are clawing back losses ahead of its Feb. 25 earnings, where analysts expect a 27% year‑over‑year revenue jump to $1.25 billion and a narrower loss of $0.65 per share. The stock remains more than 30% below its year‑to‑date high,...
TEM Q4 2025: • Revenue $367M vs Est. $363M • EPS ($0.04) vs Est. ($0.05) • Diagnostics Revenue: $267M (+122% YoY) FY26 Guidance • Revenue $1.59B vs Est. $1.58B
$AXON Reports Q4 (Dec) earnings of $2.15 per share, excluding non-recurring items, $0.55 better than the FactSet Consensus of $1.60; revenues rose 38.5% year/year to $796.72 mln vs the $755.56 mln FactSet Consensus. Co issues upside guidance for FY26, sees FY26...
Addus Homecare reported a 33.3% year‑over‑year rise in adjusted EBITDA to $50.3 million in Q4 2025, driven by a 25.6% jump in total service revenue to $373.1 million. Hospice services generated roughly $70 million, representing 18.8% of quarterly revenue, with daily census climbing...
Axon beats by $0.55, beats on revs; guides FY26 revs above consensus; provides FY28 outlook $AXON
Ziff Davis reported Q4 2025 revenue of $406.7 million, a modest 1.5% decline, as affiliate commerce commissions fell $25 million, half of which occurred in the quarter. Tech and shopping segments saw revenues drop 18‑19% year‑over‑year, driving a 14% share plunge....
Premium Earnings 2-24-26: Lowes and The Trade Desk, on the blog and here https://t.co/cXdDRXQ7dq $LOW $TTD
Home Depot reported fourth‑quarter sales of $38.2 billion, a 3.8% year‑over‑year decline, yet the results beat analyst expectations. Net income slipped 14.2% to $2.6 billion and operating income fell 14.4%, reflecting pressure from a sluggish housing market. Full‑year sales rose 3.2% to...
SmarTone posted an 8.4% rise in first‑half profit, with revenue climbing 2% to HK$3.56 billion, propelled by its premium 5G positioning and higher‑value device sales. 5G ARPU was twice that of 4G, while home broadband profit surged 36% and roaming revenue...
Cipher Digital, formerly Cipher Mining, reported Q4 revenue of $60 million and an adjusted loss of $0.14 per share, both missing analyst forecasts of $84.4 million and a $0.06 loss. The company announced a strategic pivot from bitcoin mining to high‑performance computing...
Portillo’s reported a 3.3% decline in fourth‑quarter same‑store sales and a 0.5% drop for the full year, driven largely by weak transaction growth in Texas. The chain announced new CEO Brett Patterson, succeeding interim CEO Mike Miles, who highlighted that...
Home Depot reported fiscal 2025 sales of $164.7 billion, a 3.2% increase over the prior year, driven by modest comparable sales growth. Fourth‑quarter sales slipped 3.8% to $38.2 billion, reflecting a shorter reporting period and lingering consumer uncertainty. Net earnings fell slightly...
Anglo American posted a 6% year‑over‑year rise in adjusted EBITDA to $6.9 billion, driven by higher copper and iron‑ore prices, while losses in its other divisions slashed net profit after tax 70% to $610 million. The company kept its final dividend at...
Telefonica posted a modest revenue rise of 1.3% in Q4 2025, reaching €9.174 billion, and delivered €2.069 billion in full‑year free cash flow. The group expanded its access base to 326.1 million, driven by fibre and 5G uptake, while adjusted EBITDA grew 2.8%...
Hims & Hers disclosed its fourth‑quarter earnings and announced that it has withdrawn the controversial GLP‑1 weight‑loss pill it briefly launched. The decision followed conversations with key ecosystem stakeholders, including regulators and partner pharmacies. The company highlighted modest revenue growth...
HMC Capital’s Energy Transition Fund, after buying Neoen’s Victorian renewable assets and battery developer Stor‑Energy, secured a KKR commitment of up to $603 million, falling short of its $1 billion target and prompting a 16% share decline. CEO David Di Pilla defended the...
Thomson Reuters reported full‑year 2025 organic revenue growth of 7%, driven by 9% expansion in its core Legal, Corporate and Tax & Accounting segments. Adjusted EBITDA margin rose to 39.2%, a 100‑basis‑point improvement, while free cash flow reached $1.95 billion. The...
Hershey (HSY) outlined a robust 2026 outlook, targeting 4‑5% net‑sales growth and 30‑35% earnings expansion. Management highlighted a 41% gross‑margin goal, supported by cocoa hedges that sit above current spot prices. The salty‑snacks segment posted 18% organic growth in Q4,...
Jazz Pharmaceuticals reported a record $1.126 billion Q3 2025 revenue, propelled by double‑digit growth in its sleep franchise and the successful launch of the rare‑disease drug Modesto. Xywav and Epidiolex sales rose 11% and 20% year‑over‑year, while oncology product Zepzelca saw an...
Mirion Technologies reported record 2025 orders exceeding $1.1 billion, a 26% year‑over‑year increase, driven by strong nuclear power demand and a $150 million large‑opportunity pipeline. Revenue rose 7.5% to $925.4 million, with adjusted EBITDA up 12% to $227.9 million and free cash flow doubling...
Cytokinetics announced rapid global regulatory clearance for MYCorzo, securing FDA, China NMPA, and European Commission approvals within a single week. The company launched the drug in the U.S. with over 700 REMS‑certified physicians and more than 12,000 customer engagements in...
Clean Energy Fuels reported adjusted EBITDA of $67.6 million for 2025, topping the high end of its $65 million guidance despite the loss of alternative fuel tax credits. GAGA loss widened to $222 million, mainly from non‑cash interest charges tied...
Gladstone Investment Corp reported a NAV increase to $14.95 per share, driven by $1.77 per share of unrealized appreciation and $0.09 per share of realized gains. Adjusted net investment income fell to $0.21 per share, while total assets rose to...
Fidelity National Information Services (FIS) posted Q4 2025 adjusted revenue of $2.7 billion, up 6.3% year‑over‑year, and lifted its full‑year revenue growth outlook to 5.4‑5.7%. Adjusted EBITDA margin expanded to 41.8% with a sequential 200‑basis‑point improvement, while free cash flow conversion...
Orthofix Medical reported fourth‑quarter 2020 net sales of $118 million, a 3% decline year‑over‑year but a 6% sequential increase. Spine implant revenue grew 9% YoY, propelled by an 11% rise in U.S. M6 disc sales, while motion‑preservation revenue jumped 129% YoY....
Herc Holdings reported a transformative fourth‑quarter 2025, with equipment rental revenue climbing 24% year‑over‑year after the June H&E acquisition and strong mega‑project demand. Adjusted EBITDA rose 19% to $2.0‑2.1 billion for 2026 guidance, while used equipment sales surged 53% but pressured...
Medifast reported Q4 2025 revenue of $75.1 million, down 36.9% year‑over‑year, as the active earning coach base shrank 40.6% to roughly 16,100. Despite the top‑line decline, average revenue per coach increased 6.2% to $4,664, marking the first year‑over‑year productivity gain since...
Harmony Biosciences reported $714.7 million net product revenue for 2024, a 23% year‑over‑year increase, with Q4 sales of $201.3 million driven largely by its flagship narcolepsy drug Wakix. The company announced a generic settlement with Novogen that postpones competition until at least...
Leonardo DRS reported Q2 FY2025 revenue of $829 million, up 10% year‑over‑year, and adjusted EBITDA of $96 million, expanding margin to 11.6%. Bookings reached $853 million with a 1.0 book‑to‑bill ratio and total backlog grew 9% to $8.6 billion. The company raised its full‑year...
Chimera Investment Corporation reported Q4 2025 GAAP net income of $7 million ($0.08 per share) and a full‑year profit of $144 million. The board increased the quarterly dividend 22% to $0.45 and signaled it will remain at that level through 2026. Integration...
Henry Schein reported $3.4 billion in Q4 2025 sales, a 7.7% increase and the strongest growth in over three years. Non‑GAAP operating margin held at 7.42% while cash flow from operations jumped to $381 million. Cloud‑based Dentrix Ascend reached over 11,000 subscribers,...
Xenia Hotels & Resorts reported a Q3 2025 net loss of $13.7 million while generating $42.2 million of adjusted EBITDAre and 23 cents adjusted FFO per share, an 8% YoY decline. Same‑property RevPAR was flat, but excluding the Houston market the portfolio saw...
Procore Technologies reported Q4 FY2025 revenue of $349 million, a 15.6% year‑over‑year increase, and a non‑GAAP operating margin of 15%. The company added 2,700 $100,000‑plus ARR customers, now representing 66% of total ARR, and saw free cash flow rise 69% to...
International General Insurance Holdings (IGIC) posted Q3 2025 net income of $33.5 million and $94.9 million for the first nine months, delivering a 20% annualized return on equity. The company saw gross premiums written dip 5% in Q3, driven by long‑tail pressure,...
Westlake Chemical Partners reported Q3 2025 net income of $15 million ($0.42 per unit) and consolidated net sales of $3.09 billion, reflecting the completion of the Petro 1 ethylene unit turnaround. Distributable cash flow matched earnings at $15 million but fell $3 million short of...
Interface Inc. reported third‑quarter net sales of $364.5 million, a 5.9% increase year over year and 4.2% on a currency‑neutral basis. Adjusted gross profit margin rose 208 basis points to 39.5%, while adjusted operating income grew 24.5% to $54.1 million and EPS...
Vanda Pharmaceuticals reported a 9% rise in total revenue to $216.1 million for 2025, driven primarily by a 24% jump in Fanapt sales and a successful bipolar disorder launch. The company secured FDA approval for tradipitant (Nirius) for motion‑sickness prevention, marking...
Centene reported full‑year 2025 adjusted diluted EPS of $2.08 and a Q4 loss of $1.19 per share, impacted by a $389 million Magellan divestiture charge. Management forecast 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, driven by Medicaid...
Globus Medical reported a record $2.519 billion revenue for 2024, up 61% year‑over‑year, and a non‑GAAP EPS of $3.04, a 31% increase. Free cash flow surged 145% to $405 million, allowing the company to eliminate its remaining $1 billion merger debt by Q1 2025....
Life Time Group Holdings reported Q2 2025 revenue of $761 million, up 14% year‑over‑year, driven by higher membership dues, enrollment fees, and incentive revenue. Net income rose 36.5% to $72.1 million, while adjusted EBITDA reached $211 million with a 27.7% margin, reflecting strong...
